A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly influence how cancer patients respond to immunotherapy.

Total neoadjuvant therapy demonstrates consistent real-world efficacy across regimens in patients with locally advanced rectal cancer, a study finds.

Researchers explain that in comparison to adults born in 1950, those born in 1990 are twice as likely to develop colon cancer — and a whopping four times more likely to develop rectal cancer.

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

Understanding the risk factors of colorectal cancer can help you reduce the chances of developing it. Find out what steps you can take.

Why is colorectal cancer affecting more young people, and what can be done to prevent it?

The cancer registry provides data on every new case of cancer in the state. Advocates and physicians say without it, cancer research won’t look the same.

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

A recent study in Nature Communications, by Dr. Pauliina Munne and others, provides insight into why some patients with breast cancer do not respond to therapy. Munne is a scientist in the ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, according to early trial findings.

Even though rectal bleeding is alarming, doctors say patients are ashamed to mention it, delaying colon cancer diagnosis and treatment.